Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 16;25(2):767-774.
doi: 10.1093/europace/euac202.

Sense-B-noise: an enigmatic cause for inappropriate shocks in subcutaneous implantable cardioverter defibrillators

Affiliations

Sense-B-noise: an enigmatic cause for inappropriate shocks in subcutaneous implantable cardioverter defibrillators

Andreas Haeberlin et al. Europace. .

Abstract

Aims: Subcutaneous implantable cardioverter defibrillators (S-ICDs) are well established. However, inappropriate shocks (IAS) remain a source of concern since S-ICDs offer very limited troubleshooting options. In our multicentre case series, we describe several patients who experienced IAS due to a previously unknown S-ICD system issue.

Methods and results: We observed six patients suffering from this novel IAS entity. The IAS occurred exclusively in primary or alternate S-ICD sensing vector configuration (therefore called 'Sense-B-noise'). IAS were caused by non-physiologic oversensing episodes characterized by intermittent signal saturation, diminished QRS amplitudes, and disappearance of the artefacts after the IAS. Noise/oversensing could not be provoked by manipulation, X-ray did not show evidence for lead/header issues and impedance measurements were within normal limits. The pooled experience of our centres implies that up to ∼5% of S-ICDs may be affected. The underlying root cause was discussed extensively with the manufacturer but remains unknown and is under further investigation.

Conclusion: Sense-B-noise is a novel cause for IAS due to non-physiologic signal oversensing, arising from a previously unknown S-ICD system issue. Sense-B-noise may be suspected if episodes of signal saturation in primary or alternate vector configuration are present, oversensing cannot be provoked, and X-ray and electrical measurements appear normal. The issue can be resolved by reprogramming the device to secondary sensing vector.

Keywords: Device failure; Inappropriate shock; Oversensing; S-ICD; Subcutaneous defibrillator.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None of the authors has received any compensation for this study. Haeberlin has received travel/educational grants from Medtronic and Philips/Spectranetics. He is consultant/advisor for DiNAQOR and Biotronik and Co-founder/head of Act-Inno. Burri has received institutional fellowship support and/or speaker fees from Abbott, Biotronik, Boston Scientific, Medtronic, and Microport. Schaer has received fees from Medtronic’s speaker’s bureau. Koepfli has received consultant fees from Microport, and speaker fees von Medtronic, Abbott Medical und Daiichi Sankyo. Grebmer received speaker fees from Abbott and Zoll, and received travel support from Biotronik. Breitenstein has received consultant and/or speaker fees from Abbott, Bayer Healthcare, Biosense Webster, Biotronik, Boston Scientific, Bristol-Myers Squibb, Cook Medical, Daiichi Sankyo, Medtronic, Pfizer, and Spectranetics/Philipps. Reichlin has received consulting fees/speaker honoraria/travel support from Abbott, Astra Zeneca, Brahms, Bayer, Biosense-Webster, Biotronik, Boston-Scientific, Daiichi Sankyo, Medtronic, Pfizer-BMS, and Roche. Noti has received travel/educational grants from Medtronic and Abbott, Boston Scientific and Philips/Spectranetics and speaker honoraria from Medtronic and Abbott.

Figures

Figure 1
Figure 1
Inappropriate shock due to oversensing (Case #1). The episode begins with a sudden artefact driving the signal into saturation (1). Subsequently, the cardiac signal becomes largely unrecognizable with low-amplitude signals (2), and the S-ICD starts to charge (3, charging artefact). The shock delivery is ensued by normal QRS signal amplitudes (4).
Figure 2
Figure 2
Patient Case #2. Panel (A) inappropriate shock due to artefact oversensing. Signal saturation episodes are visible (asterisks), the low-amplitude QRS becomes better visible after the IAS. Panel (B) similar to Figure 1, the episode is triggered by a sudden artefact (1). The ensuing artefact-rich signal shows episodes of signal saturation and oversensing.
Figure 3
Figure 3
Patient Case #3. Panel (A) patient with IAS inducing ventricular fibrillation. The shock is preceded by an artefact-rich signal with episodes of signal saturation (asterisks). Panel (B) shows the following second shock. Panel (C) remote monitoring of the patient in secondary vector. Episodes as shown in panel (A) were not registered anymore. However, intermittent T-wave oversensing (1) and QRS undersensing (2) occurred. Myopotential noise was appropriately classified by the device (3).
Figure 4
Figure 4
Patient Case #4. Panel (A) heavily diminished ECG signal amplitudes causing oversensing and shock delivery. Panel (B) similar episode 2 days later. Both episodes (panel B and C) showing QRS amplitude restoration after shock delivery.
Figure 5
Figure 5
Simplified flowchart for the diagnosis and management of inadequate S-ICD shocks of non-cardiac origin. Initial diagnostic steps (yellow boxes) mostly allow identifying the cause for the IAS (red boxes). Dashed arrows indicate diagnostic key hints. If the findings remain unclear or unsuspicious, the manufacturer’s technical service should be involved. Green boxes show general management recommendations. Abbreviations: AC, alternating current; IAS, inadequate shock.

Similar articles

Cited by

References

    1. Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M et al. . Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 2013;128:944–53. - PubMed
    1. Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil Pet al. . Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study. J Am Coll Cardiol 2017;70:830–41. - PubMed
    1. Gold MR, Lambiase PD, El-Chami MF, Knops RE, Aasbo JD, Bongiorni MG et al. . Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) trial. Circulation 2021;143:7–17. - PMC - PubMed
    1. Lambiase PD, Theuns DA, Murgatroyd F, Barr C, Eckardt L, Neuzil Pet al. . Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study. Eur Heart J 2022. online. - PMC - PubMed
    1. Knops RE, Olde Nordkamp LRA, Delnoy P-PHM, Boersma LVA, Kuschyk J, El-Chami MF et al. . Subcutaneous or transvenous defibrillator therapy. N Engl J Med 2020;383:526–36. - PubMed

MeSH terms